|
🐜
|
Revision of the American Joint Committee on Cancer staging system for breast cancer.
20 auth.
S. Singletary,
C. Allred,
P. Ashley,
L. Bassett,
D. Berry,
K. Bland,
P. Borgen,
G. Clark,
S. Edge,
D. Hayes,
...
L. Hughes,
R. Hutter,
M. Morrow,
D. Page,
A. Recht,
R. Theriault,
A. Thor,
D. Weaver,
H. Wieand,
F. Greene
|
10 |
2002 |
10
🐜
|
|
🐜
|
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
14 auth.
N. Kauff,
J. Satagopan,
M. Robson,
Lauren Scheuer,
M. Hensley,
C. Hudis,
N. Ellis,
J. Boyd,
P. Borgen,
R. Barakat,
...
L. Norton,
M. Castiel,
K. Nafa,
K. Offit
|
10 |
2002 |
10
🐜
|
|
🐜
|
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
9 auth.
K. J. Zee,
Donna-Marie Manasseh,
J. Bevilacqua,
S. Boolbol,
J. Fey,
L. Tan,
...
P. Borgen,
H. Cody,
M. Kattan
|
9 |
2003 |
9
🐜
|
|
🐜
|
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
12 auth.
Lauren Scheuer,
N. Kauff,
M. Robson,
B. Kelly,
R. Barakat,
J. Satagopan,
...
N. Ellis,
M. Hensley,
J. Boyd,
P. Borgen,
L. Norton,
K. Offit
|
8 |
2002 |
8
🐜
|
|
🐜
|
Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers
7 auth.
D. Levine,
F. Bogomolniy,
C. Yee,
A. Lash,
R. Barakat,
P. Borgen,
...
J. Boyd
|
8 |
2005 |
8
🐜
|
|
🐜
|
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 Procedures
13 auth.
A. Naik,
J. Fey,
M. Gemignani,
A. Heerdt,
L. Montgomery,
J. Petrek,
E. Port,
V. Sacchini,
L. Sclafani,
K. VanZee,
...
R. Wagman,
P. Borgen,
H. Cody
|
8 |
2004 |
8
🐜
|
|
🐜
|
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
13 auth.
C. Oddoux,
J. Struewing,
C. Clayton,
S. Neuhausen,
L. Brody,
M. Kaback,
B. Haas,
L. Norton,
P. Borgen,
S. Jhanwar,
...
D. Goldgar,
H. Ostrer,
K. Offit
|
8 |
1996 |
8
🐜
|
|
🐜
|
Lessons learned from 500 cases of lymphatic mapping for breast cancer.
8 auth.
A. Hill,
K. Tran,
T. Akhurst,
H. Yeung,
S. Yeh,
P. Rosen,
...
P. Borgen,
H. Cody
|
8 |
1999 |
8
🐜
|
|
🐢
|
Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
17 auth.
V. Sacchini,
J. Pinotti,
A. Barros,
A. Luini,
A. Pluchinotta,
M. Pinotti,
M. G. Boratto,
M. Ricci,
C. Ruiz,
A. Nisida,
...
P. Veronesi,
J. Petit,
P. Arnone,
F. Bassi,
J. Disa,
C. Garcia-Etienne,
P. Borgen
|
8 |
2006 |
8
🐢
|
|
🐜
|
BRCA-associated breast cancer in young women.
12 auth.
M. Robson,
T. Gilewski,
B. Haas,
D. Levin,
P. Borgen,
P. Rajan,
...
Y. Hirschaut,
P. Pressman,
P. Rosen,
Martin L. Lesser,
L. Norton,
K. Offit
|
8 |
1998 |
8
🐜
|
|
🐜
|
Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?
12 auth.
Nancy Klauber-DeMore,
L. Tan,
L. Liberman,
Stamatina Kaptain,
J. Fey,
P. Borgen,
...
A. Heerdt,
L. Montgomery,
M. Paglia,
J. Petrek,
H. Cody,
K. J. Zee
|
8 |
2000 |
8
🐜
|
|
🐜
|
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
14 auth.
S. Neuhausen,
T. Gilewski,
L. Norton,
T. Tran,
P. McGuire,
J. Swensen,
H. Hampel,
P. Borgen,
K. Brown,
M. Skolnick,
...
D. Shattuck-Eidens,
S. Jhanwar,
D. Goldgar,
K. Offit
|
8 |
1996 |
8
🐜
|
